Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic stem cell disorders characterized by defects in myeloid differentiation and increased proliferation of neoplastic hematopoietic precursor cells. Outcomes for patients with AML remain poor, highlighting the need for novel treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Chengyin, Moore, Nathan, Shearstone, Jeffrey R., Quayle, Steven N., Huang, Pengyu, van Duzer, John H., Jarpe, Matthew B., Jones, Simon S., Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218480/
https://www.ncbi.nlm.nih.gov/pubmed/28060870
http://dx.doi.org/10.1371/journal.pone.0169128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218480/
https://www.ncbi.nlm.nih.gov/pubmed/28060870
http://dx.doi.org/10.1371/journal.pone.0169128

Ejemplares similares